The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study | MicrobiomeTrials← Back to trialsNCT07538609
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-08-25Est. Completion: 2029-05
Enrollment target: 150 participants Locations- Vascular Care Connecticut, Darien, Connecticut, United States
- Medstar Washington Haspital Center, Washington D.C., District of Columbia, United States
- Baylor Research Institute, Dallas, Texas, United States
- UW Medical Center - Northwest Vascular Care, Seattle, Washington, United States
Other microbiome trials you might be interested in
Traumatic Brain InjuryIntracranial Hemorrhages
Elderly patients on direct oral anticoagulants (DOACs), specifically factor Xa (FXa) inhibitors such as apixaban and riv…
Ljubljana, SloveniaCompleted Aug 1, 2026
Infraclavicular Vein CannulationVenous Cannulation
Central venous cannulation is an essential procedure in the anaesthetic and critical care practice. Ultrasound has revol…
Alexandria, EgyptCompleted Jul 1, 2026
Neurocognitive DisordersPostoperative DeliriumPostoperative Outcomes
The overall goal of this study is to explore the effects of perioperative oral creatine supplementation on cognitive fun…
Multiple LocationsEst. completion Oct 30, 2028